Scientists Wanted Transparency From Theranos, But Got A Product Launch Instead | Fast Company | Business + Innovation
▻http://www.fastcompany.com/3062433/scientists-wanted-transparency-from-theranos-but-got-a-product-launch-i
Theranos once promised to revolutionize the blood testing industry. But its methodology remains secretive, despite calls for transparency from the scientific community. Now, it is facing federal investigations, private litigation, voided tests, and its CEO, Elizabeth Holmes, is banned from operating a lab for two years.
But all that was entirely glossed over today at the company’s much-awaited first presentation to the scientific community at the American Association for Clinical Chemistry’s conference in Philadelphia.
In an hour-long presentation (you can review the slides here ▻https://www.aacc.org/~/media/files/annual-meeting/2016/theranosaaccpresentation.pdf ), Holmes failed to discuss the fate of the company’s proprietary blood-testing technology, Edison, or address any of the controversy. Instead, she skipped right to pitching a new product, dubbed the MiniLab.
[…]
“Clearly, the scientific and medical community was hoping for a data-driven discussion today, and instead got a new product announcement,” says John Torous, a psychiatrist and clinical informatics fellow at Harvard Medical School.